Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DEAD box polypeptide 18 pseudogene 2 (DDX18P2) is a human pseudogene, meaning it resembles a protein-coding gene (in this case, DDX18, a DEAD-box RNA helicase) but does *not* encode a functional protein product[1]. Like other pseudogenes, DDX18P2 may exist due to duplication or mutation events in the genome and lacks evidence for its transcription into a functional protein. Therefore, DDX18P2 is not considered a therapeutic target, does not belong to known druggable protein families (such as receptor, enzyme, transporter, or channel), and has no established biological or clinical relevance.\n\nFor context: DDX18 (not the pseudogene) is a bona fide RNA helicase involved in RNA processing and ribosome biogenesis and participates in several essential cellular processes[5][7]. The pseudogene DDX18P2 is related by sequence but is non-functional and should not be confused with the protein-coding gene DDX18.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DEAD box polypeptide 18 pseudogene 2 (DDX18P2).